Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 540 | 440 | 330 | 1,340 | 13,790 |
| Gross Profit | 540 | 440 | 330 | 1,340 | 13,790 |
| Operating Expenses | 5,339 | 5,153 | 5,663 | 6,785 | 8,138 |
| Operating Income | -4,799 | -4,713 | -5,333 | -5,445 | 5,652 |
| Other Income | -181 | -167 | -607 | 605 | 1,458 |
| Pre-tax Income | -4,980 | -4,880 | -5,940 | -4,840 | 7,110 |
| Income Tax | 0 | 50 | -10 | 70 | -130 |
| Net Income Continuous | -4,980 | -4,930 | -5,930 | -4,910 | 7,240 |
| Net Income | $-4,980 | $-4,930 | $-5,930 | $-4,910 | $7,240 |
| EBITDA(a) | $-4,619 | $-4,473 | $-5,103 | $-5,235 | $5,922 |